17-1853102-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_002945.5(RPA1):c.274A>G(p.Arg92Gly) variant causes a missense, splice region change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Consequence
RPA1
NM_002945.5 missense, splice_region
NM_002945.5 missense, splice_region
Scores
3
9
7
Splicing: ADA: 0.8597
2
Clinical Significance
Conservation
PhyloP100: 6.14
Genes affected
RPA1 (HGNC:10289): (replication protein A1) This gene encodes the largest subunit of the heterotrimeric Replication Protein A (RPA) complex, which binds to single-stranded DNA (ssDNA), forming a nucleoprotein complex that plays an important role in DNA metabolism, being involved in DNA replication, repair, recombination, telomere maintenance, and co-ordinating the cellular response to DNA damage through activation of the ataxia telangiectasia and Rad3-related protein (ATR) kinase. The nucleoprotein complex protects the single-stranded DNA from nucleases, prevents formation of secondary structures that would interfere with repair, and co-ordinates the recruitment and departure of different genome maintenance factors. This subunit contains four oligonucleotide/oligosaccharide-binding (OB) domains, though the majority of ssDNA binding occurs in two of these domains. The heterotrimeric complex has two different modes of ssDNA binding, a low-affinity and high-affinity mode, determined by which ssDNA binding domains are utilized. The different binding modes differ in the length of DNA bound and in the proteins with which it interacts, thereby playing a role in regulating different genomic maintenance pathways. [provided by RefSeq, Sep 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.906
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPA1 | NM_002945.5 | c.274A>G | p.Arg92Gly | missense_variant, splice_region_variant | 5/17 | ENST00000254719.10 | NP_002936.1 | |
RPA1 | NM_001355120.2 | c.235A>G | p.Arg79Gly | missense_variant, splice_region_variant | 5/17 | NP_001342049.1 | ||
RPA1 | NM_001355121.2 | c.274A>G | p.Arg92Gly | missense_variant, splice_region_variant | 5/16 | NP_001342050.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPA1 | ENST00000254719.10 | c.274A>G | p.Arg92Gly | missense_variant, splice_region_variant | 5/17 | 1 | NM_002945.5 | ENSP00000254719 | P1 | |
RPA1 | ENST00000570451.5 | c.235A>G | p.Arg79Gly | missense_variant, splice_region_variant | 5/7 | 3 | ENSP00000459788 | |||
RPA1 | ENST00000571058.5 | c.235A>G | p.Arg79Gly | missense_variant, splice_region_variant | 5/6 | 4 | ENSP00000461733 | |||
RPA1 | ENST00000571725.1 | n.190A>G | splice_region_variant, non_coding_transcript_exon_variant | 3/4 | 5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 30
GnomAD4 exome
Cov.:
30
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 03, 2022 | The c.274A>G (p.R92G) alteration is located in exon 5 (coding exon 5) of the RPA1 gene. This alteration results from a A to G substitution at nucleotide position 274, causing the arginine (R) at amino acid position 92 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;.;M
MutationTaster
Benign
D
PrimateAI
Benign
T
PROVEAN
Pathogenic
.;.;D
REVEL
Uncertain
Sift
Uncertain
.;.;D
Sift4G
Uncertain
D;D;D
Polyphen
0.92
.;.;P
Vest4
0.72
MutPred
0.85
.;.;Loss of MoRF binding (P = 0.018);
MVP
MPC
0.59
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.